---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-016480"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:33:56.894586+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hyperfine Q2 revenue up 328% YoY to $1.5M; net loss $23.2M ($0.33/shr)

## Summary
- Revenue $1.533M (Q2 2022) vs $0.358M (Q2 2021); gross margin negative at ($0.165M).
- Net loss $23.159M, $0.33 loss per share vs $8.80 loss per share in prior year.
- Placed 9 commercial Swoop systems in Q2; total 20 YTD and 47 launch-to-date; installed base 92.
- FY 2022 guidance: revenue $7-8M and 35-45 commercial unit installations expected.
- Received FDA clearances for new deep-learning imaging sequences; partnered with Viz.ai for neuro ICU.

## SEC filing metadata
- accession: 0000950170-22-016480
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000095017022016480/0000950170-22-016480-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000095017022016480/hypr-20220810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-016480
- JSON: https://secwatch.observer/filing/0000950170-22-016480.json
- Plain text: https://secwatch.observer/filing/0000950170-22-016480.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.